127 related articles for article (PubMed ID: 17545634)
1. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents.
Duong V; Boulle N; Daujat S; Chauvet J; Bonnet S; Neel H; Cavaillès V
Cancer Res; 2007 Jun; 67(11):5513-21. PubMed ID: 17545634
[TBL] [Abstract][Full Text] [Related]
2. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
[TBL] [Abstract][Full Text] [Related]
3. MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.
Kim K; Burghardt R; Barhoumi R; Lee SO; Liu X; Safe S
J Mol Endocrinol; 2011 Apr; 46(2):67-79. PubMed ID: 21169420
[TBL] [Abstract][Full Text] [Related]
4. MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells.
Saji S; Okumura N; Eguchi H; Nakashima S; Suzuki A; Toi M; Nozawa Y; Saji S; Hayashi S
Biochem Biophys Res Commun; 2001 Feb; 281(1):259-65. PubMed ID: 11178989
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Swetzig WM; Wang J; Das GM
Oncotarget; 2016 Mar; 7(13):16049-69. PubMed ID: 26909605
[TBL] [Abstract][Full Text] [Related]
7. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Kundu N; Brekman A; Kim JY; Xiao G; Gao C; Bargonetti J
Oncotarget; 2017 Jul; 8(29):47916-47930. PubMed ID: 28615518
[TBL] [Abstract][Full Text] [Related]
9. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
10. p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.
Berger CE; Qian Y; Liu G; Chen H; Chen X
J Biol Chem; 2012 Aug; 287(36):30117-27. PubMed ID: 22787161
[TBL] [Abstract][Full Text] [Related]
11. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
12. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor α promotes Cav1.2 ubiquitination and degradation in neuronal cells and in APP/PS1 mice.
Lai YJ; Zhu BL; Sun F; Luo D; Ma YL; Luo B; Tang J; Xiong MJ; Liu L; Long Y; Hu XT; He L; Deng XJ; Zhang JH; Yang J; Yan Z; Chen GJ
Aging Cell; 2019 Aug; 18(4):e12961. PubMed ID: 31012223
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity.
Lewandowski SA; Thiery J; Jalil A; Leclercq G; Szczylik C; Chouaib S
Oncogene; 2005 Jul; 24(30):4789-98. PubMed ID: 15870704
[TBL] [Abstract][Full Text] [Related]
16. Roles of estrogen receptor and p21(Waf1) in bortezomib-induced growth inhibition in human breast cancer cells.
Maynadier M; Shi J; Vaillant O; Gary-Bobo M; Basile I; Gleizes M; Cathiard AM; Wah JL; Sheikh MS; Garcia M
Mol Cancer Res; 2012 Nov; 10(11):1473-81. PubMed ID: 22964432
[TBL] [Abstract][Full Text] [Related]
17. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer.
Suga S; Kato K; Ohgami T; Yamayoshi A; Adachi S; Asanoma K; Yamaguchi S; Arima T; Kinoshita K; Wake N
Gynecol Oncol; 2007 May; 105(2):341-50. PubMed ID: 17306348
[TBL] [Abstract][Full Text] [Related]
18. Estradiol stabilizes p53 protein in breast cancer cell line, MCF-7.
Okumura N; Saji S; Eguchi H; Hayashi S; Saji S; Nakashima S
Jpn J Cancer Res; 2002 Aug; 93(8):867-73. PubMed ID: 12716463
[TBL] [Abstract][Full Text] [Related]
19. MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation.
Shostak K; Patrascu F; Göktuna SI; Close P; Borgs L; Nguyen L; Olivier F; Rammal A; Brinkhaus H; Bentires-Alj M; Marine JC; Chariot A
Cell Death Differ; 2014 May; 21(5):811-24. PubMed ID: 24488098
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
Wu F; Safe S
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
